Dr. Paulraj Subbiah, Executive Chairman, ACCEPT – CSPT, India

Dr. Paulraj Subbiah

Executive Chairman, ACCEPT – CSPT, India

Presentation Title:

Revisiting the budwig diet protocol with recent research findings authenticate it as an effective evidence based anticancer therapy.

Abstract

Budwig Diet, developed in the early 1950s by the German chemist Dr. Johanna Budwig (1908–2003) was a popular alternative cancer therapy during her periods when there was no any effective conventional therapy existing for treating Cancer. Although it is still widely practiced all over the world for cancer treatment as an evidence based alternative therapy, it is not an approved drug by the FDA for treating cancer. However, the evidence-based therapies are popular in Asian and African countries and people are using them as the main or alternative therapy for various diseases especially for cancer. In order to validate its use as an evidence-based therapy for cancer treatment, the anti-cancer properties of the active ingredients present in the Budwig Diet are analysed for their anti-cancer properties with recent scientific findings and clinical trials.

Biography

S. Paulraj has completed his PHD in Zoology at the age of 30 years from the University of Madras, INDIA. He is now the CEO of the Advanced Centre for Conservation Education, of the CSPT, Chennai, India. He is basically from Forest Service. He developed interest in Cancer Biology after his complete recovery from his Rectal Cancer, stage III by practicing alternative medicines followed by initial conventional therapy. In association with research institutions, he continues his research on Cancer biology with special reference to evidence based alternative anticancer therapy and has published five review articles on this subject. He is the author one Book on Alternative Medicines for Cancer prevention in the local language, Tamil for the benefit of local people. He is now actively involved in counselling Cancer patients and suggesting alternative medical treatments available, especially for those who lost hopes in conventional treatment.